Literature DB >> 19669093

Regulation of estrogen receptor beta activity and implications in health and disease.

Elin Swedenborg1, Krista A Power, Wen Cai, Ingemar Pongratz, Joëlle Rüegg.   

Abstract

Together with the estrogen receptor (ER) alpha, estrogen receptor beta (ER beta ) mediates many of the physiological effects of estrogens. As ER beta is crucially involved in a variety of important physiological processes, its activity should be tightly regulated. ER beta regulation is achieved by hormone binding as well as by posttranslational modifications of the receptor. Furthermore, ER beta expression levels are under circadian control and can be regulated by DNA methylation of the ER beta promoter region. There are also a number of factors that can interfere with ER beta activity, such as phytoestrogens, endocrine disruptive chemicals, and growth factors. In this article, we outline different mechanisms of ER beta regulation and how they are implicated in various diseases. We also discuss how these insights might help to specifically target ER beta in drug design.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19669093     DOI: 10.1007/s00018-009-0118-z

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  200 in total

1.  Genome-wide analysis of estrogen receptor binding sites.

Authors:  Jason S Carroll; Clifford A Meyer; Jun Song; Wei Li; Timothy R Geistlinger; Jérôme Eeckhoute; Alexander S Brodsky; Erika Krasnickas Keeton; Kirsten C Fertuck; Giles F Hall; Qianben Wang; Stefan Bekiranov; Victor Sementchenko; Edward A Fox; Pamela A Silver; Thomas R Gingeras; X Shirley Liu; Myles Brown
Journal:  Nat Genet       Date:  2006-10-01       Impact factor: 38.330

2.  Estrogen receptor beta acts as a dominant regulator of estrogen signaling.

Authors:  K Pettersson; F Delaunay; J A Gustafsson
Journal:  Oncogene       Date:  2000-10-12       Impact factor: 9.867

3.  Dietary genistein negates the inhibitory effect of tamoxifen on growth of estrogen-dependent human breast cancer (MCF-7) cells implanted in athymic mice.

Authors:  Young H Ju; Daniel R Doerge; Kimberly F Allred; Clinton D Allred; William G Helferich
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

4.  The proto-oncoprotein Brx activates estrogen receptor beta by a p38 mitogen-activated protein kinase pathway.

Authors:  P H Driggers; J H Segars; D M Rubino
Journal:  J Biol Chem       Date:  2001-09-28       Impact factor: 5.157

5.  Correlating androgen and estrogen steroid receptor expression with coronary calcification and atherosclerosis in men without known coronary artery disease.

Authors:  Peter Y Liu; Rose C Christian; Ming Ruan; Virginia M Miller; Lorraine A Fitzpatrick
Journal:  J Clin Endocrinol Metab       Date:  2004-11-09       Impact factor: 5.958

6.  Expression of estrogen receptor beta isoforms in normal breast epithelial cells and breast cancer: regulation by methylation.

Authors:  Chunyan Zhao; Eric W-F Lam; Andrew Sunters; Eva Enmark; Manuela Tamburo De Bella; R Charles Coombes; Jan-Ake Gustafsson; Karin Dahlman-Wright
Journal:  Oncogene       Date:  2003-10-23       Impact factor: 9.867

7.  Differential expression of estrogen receptor-alpha and -beta messenger RNAs as a potential marker of ovarian carcinogenesis.

Authors:  P Pujol; J M Rey; P Nirde; P Roger; M Gastaldi; F Laffargue; H Rochefort; T Maudelonde
Journal:  Cancer Res       Date:  1998-12-01       Impact factor: 12.701

8.  The basic helix-loop-helix-PAS protein ARNT functions as a potent coactivator of estrogen receptor-dependent transcription.

Authors:  Sara Brunnberg; Katarina Pettersson; Elin Rydin; Jason Matthews; Annika Hanberg; Ingemar Pongratz
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-16       Impact factor: 11.205

9.  Role of ERbeta palmitoylation in the inhibition of human colon cancer cell proliferation.

Authors:  Paola Galluzzo; Francesco Caiazza; Sandra Moreno; Maria Marino
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

10.  Xenoestrogens modulate vascular endothelial growth factor secretion in breast cancer cells through an estrogen receptor-dependent mechanism.

Authors:  Hélène Buteau-Lozano; Guillaume Velasco; Monique Cristofari; Patrick Balaguer; Martine Perrot-Applanat
Journal:  J Endocrinol       Date:  2008-02       Impact factor: 4.286

View more
  25 in total

1.  Selenophenes: Introducing a New Element into the Core of Non-Steroidal Estrogen Receptor Ligands.

Authors:  Silong Zhang; Zhiyong Wang; Zhiye Hu; Changhao Li; Chu Tang; Kathryn E Carlson; Junjie Luo; Chune Dong; John A Katzenellenbogen; Jian Huang; Hai-Bing Zhou
Journal:  ChemMedChem       Date:  2017-01-09       Impact factor: 3.466

2.  Development of an updated phytoestrogen database for use with the SWAN food frequency questionnaire: intakes and food sources in a community-based, multiethnic cohort study.

Authors:  Mei-Hua Huang; Jean Norris; Weijuan Han; Torin Block; Ellen Gold; Sybil Crawford; Gail A Greendale
Journal:  Nutr Cancer       Date:  2012-01-02       Impact factor: 2.900

3.  Ancestral resurrection of anthropoid estrogen receptor β demonstrates functional consequences of positive selection.

Authors:  Amy Weckle; Michael R McGowen; Jun Xing; Caoyi Chen; Kirstin N Sterner; Zhuo-Cheng Hou; Roberto Romero; Derek E Wildman
Journal:  Mol Phylogenet Evol       Date:  2017-09-13       Impact factor: 4.286

4.  The prognostic factors of recurrence and survival in female patients with lung adenocarcinoma and breast cancer.

Authors:  Ying-Yi Chen; Yi-Jhih Huang; Hsu-Kai Huang; Hung Chang; Shih-Chun Lee; Yi-Shing Shieh; Tsai-Wang Huang
Journal:  J Cancer Res Clin Oncol       Date:  2020-02-27       Impact factor: 4.553

5.  Clinical implications of ERβ methylation on sporadic breast cancers in Chinese women.

Authors:  Lin Zhao; Zhaojin Yu; Yunan Li; Xiaoyan Wen; Wenfeng Ma; Lin Wang; Jie Ren; Caigang Liu; Miao He; Xuefeng Bai; Mingli Sun; Zhihong Zheng; Xiaoyi Mi; Enhua Wang; Olufunmilayo I Olopade; Feng Jin; Minjie Wei
Journal:  Med Oncol       Date:  2011-11-22       Impact factor: 3.064

6.  Potential clinical significance of ERβ ON promoter methylation in sporadic breast cancer.

Authors:  Ana Božović; Milan Markićević; Bogomir Dimitrijević; Snežana Jovanović Ćupić; Milena Krajnović; Silvana Lukić; Vesna Mandušić
Journal:  Med Oncol       Date:  2013-06-22       Impact factor: 3.064

Review 7.  Regulation of physiological and metabolic function of muscle by female sex steroids.

Authors:  Espen E Spangenburg; Paige C Geiger; Leslie A Leinwand; Dawn A Lowe
Journal:  Med Sci Sports Exerc       Date:  2012-09       Impact factor: 5.411

8.  Thiophene-core estrogen receptor ligands having superagonist activity.

Authors:  Jian Min; Pengcheng Wang; Sathish Srinivasan; Jerome C Nwachukwu; Pu Guo; Minjian Huang; Kathryn E Carlson; John A Katzenellenbogen; Kendall W Nettles; Hai-Bing Zhou
Journal:  J Med Chem       Date:  2013-04-15       Impact factor: 7.446

9.  Modulation of estrogenic action in clear cell carcinoma of the ovary (Review).

Authors:  Yasuhito Tanase; Yoshihiko Yamada; Hiroshi Shigetomi; Hirotaka Kajihara; Akira Oonogi; Yoriko Yoshizawa; Naoto Furukawa; Shoji Haruta; Shozo Yoshida; Toshiyuki Sado; Hidekazu Oi; Hiroshi Kobayashi
Journal:  Exp Ther Med       Date:  2011-10-24       Impact factor: 2.447

10.  Design of pathway preferential estrogens that provide beneficial metabolic and vascular effects without stimulating reproductive tissues.

Authors:  Zeynep Madak-Erdogan; Sung Hoon Kim; Ping Gong; Yiru C Zhao; Hui Zhang; Ken L Chambliss; Kathryn E Carlson; Christopher G Mayne; Philip W Shaul; Kenneth S Korach; John A Katzenellenbogen; Benita S Katzenellenbogen
Journal:  Sci Signal       Date:  2016-05-24       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.